Cemcat (Centre D'Esclerosi Múltiple De Catalunya)

Cemcat (Centre D'Esclerosi Múltiple De Catalunya) company information, Employees & Contact Information

CEMCAT, Multiple Sclerosis Center of Catalonia, is a world reference center in the diagnosis and comprehensive treatment of multiple sclerosis, as well as in the research of new drugs and specialized training of multiple sclerosis professionals. Under the direction of Dr. Xavier Montalban, Head of the Neurology-Neuroimmunology Service of the Vall d'Hebron University Hospital, CEMCAT seeks to provide a comprehensive response to patients with neuroimmunological diseases, especially multiple sclerosis. Our goal is to improve their state of health and achieve the highest degree of quality of life. Every year more than 3,000 patients, 30% of those affected by multiple sclerosis in Catalonia, receive care at our center. The current CEMCAT building, inaugurated in 2012, has facilities of almost 2,000 m2 divided into 3 floors that include Consultations, Day Hospital, Neurorehabilitation Area, Independent Living Laboratory, etc. This infrastructure allows us to offer patients diagnostic assistance, treatment and rehabilitation services, as well as to participate in clinical trials and research, if they wish, without leaving the center located in the Vall d'Hebron Hospital Campus in Barcelona. Our team is made up of a group of 70 multidisciplinary professionals (neurologists, researchers, neuropsychologists, nurses, physiotherapists, assistants, occupational therapists and social workers) of recognized expertise in the field of rehabilitation who work every day to stop the impact of multiple sclerosis on patients and their environment.

Company Details

Employees
53
Address
Passeig Vall D'hebron 119- 129, Campus Hospitalari Vall D'hebron,spain
Industry
Hospitals And Health Care
NAICS
Health Care and Social Assistance
Social Assistance
HQ
Barcelona, Cataluña / Catalunya
Looking for a particular Cemcat (Centre D'Esclerosi Múltiple De Catalunya) employee's phone or email?

Cemcat (Centre D'esclerosi Múltiple De Catalunya) Questions

News

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis - Neurology® Journals

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis Neurology® Journals

Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis - Frontiers

Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis Frontiers

Vall d'Hebron shows that starting medication in patients - Vall d'Hebron Barcelona Hospital Campus

Vall d'Hebron shows that starting medication in patients Vall d'Hebron Barcelona Hospital Campus

Therapeutic inertia in the management of neuromyelitis optica spectrum disorder - Frontiers

Therapeutic inertia in the management of neuromyelitis optica spectrum disorder Frontiers

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis - Neurology® Journals

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis Neurology® Journals

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study - Frontiers

An expert patient program to improve the empowerment and quality of life of people with multiple sclerosis: protocol for a multicenter pre-post intervention study Frontiers

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant